Novartis Investigative Site

Trutnov, Czech Republic 541 01

0 studies enrolling now · 3 studies all time

What they study most

Asthma

Studies at this site

• Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma — Completed
• Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201 — Stopped early
• A Study to Assess the Effect of QAW039 in Non-atopic Asthmatic Patients — Completed